1-2 of 2
Steve Kye, MD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study

Jacqueline S. Garcia, MD, Andrew H. Wei, Uma Borate, Chun Yew Fong, MBBS, PhD FRACP, FRCPA, Maria R. Baer, MD, Florian Nolte, MD, Joseph G. Jurcic, MD, Meagan A. Jacoby, MD, Wan-Jen Hong, MD, Uwe Platzbecker, Olatoyosi Odenike, MD, Ilona Cunningham, MBBS, FRACP, FRCPA, Ying Zhou, PhD, Bo Tong, PhD, Leah Hogdal, PhD, Rajesh Kamalakar, MS, Jessica E. Hutti, PhD, Steve Kye, MD MPH, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 55–57.
https://doi.org/10.1182/blood-2020-139492
Published: 2020
Journal Articles

Characteristics and Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Receiving Venetoclax Combinations Vs Other Therapies: Results from the AML Real World Evidence (ARC) Initiative

Daniel A. Pollyea, Maximilian Stahl, Chetasi Talati, MD, Hannah Asghari, MD BS, Catherine Lai, MD MPH, Sameem Abedin, MD, Joshua F. Zeidner, MD, Benyam Muluneh, PharmD, Marin Xavier, Wesleigh Edwards, MD PhD, Ofir Wolach, MD, Yakir Moshe, MDPhD, David Lavie, MD, Tsila Zuckerman, MD, Michelle Choi, Cat N. Bui, PhD, Anders Erik Svensson, MD, Steve Kye, MD MPH, Rebecca Burne, Annie Guerin, MSc, Esprit Ma, Melissa Montez, Aaron D Goldberg, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–28.
https://doi.org/10.1182/blood-2020-134789
Published: 2020